Avita Medical Ltd (AVH) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Avita Medical Ltd (AVH) - Medical Equipment - Deals and Alliances Profile

Avita Medical Ltd (AVH) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Avita Medical Ltd (AVH) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
73 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Avita Medical Ltd (Avita Medical) is a medical device company that develops and distributes regenerative, tissue-engineered products for treating burns, scars, wounds, and skin defects. The company's medical devices work by preparing a Regenerative Epithelial Suspension which is derived using the patients own skin. The companys medical device portfolio includes ReCell, designed for the treatment of burns and plastic reconstructive procedures; ReGenerCell, aimed for chronic wounds including leg and foot ulcers; and ReNovaCell, targeting aesthetic applications including the restoration of pigmentation.

Avita Medical Ltd (AVH) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal t

  
Source:
Document ID
GDME59513D
Country
Industry
Ticker
AVH=GB
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
Avita Medical Ltd, Medical Equipment, Deals By Year, 2010 to YTD 201652
Avita Medical Ltd, Medical Equipment Deals By Type, 2010 to YTD 201671
Avita Medical Ltd, Medical Equipment, Deals By Region, 2010 to YTD 201681
Avita Medical Ltd, Medical Equipment, Deals By Market, 2010 to YTD 201691
Avita Medical Ltd, Medical Equipment, Deals Summary, 2010 to YTD 2016101
Avita Medical Ltd, Medical Equipment, Deal Details1118
  Asset Purchase111
    Avita Medical Acquires Intellectual Property From McComb Foundation111
  Partnerships121
    Avita Medical Enters into Distribution Agreement with Sinopharm121
    Avita Medical Enters into Distribution Agreement with Medical Z131
    Avita Medical Extends Contract with BARDA141
    Avita Medical Enters into Agreement with University of Huddersfield151
  Equity Offering161
    Avita Medical Raises USD6.74 Million in Rights Offering of Shares162
    Avita Medical Raises USD7.3 Million in Private Placement of Shares182
    Avita Medical Completes Rights Offering Of Shares For US$3 Million201
    Avita Medical Completes First Tranche Of Private Placement Of Shares For US$0.5 Million211
    Avita Medical Completes First Tranche Of Private Placement Of Shares For US$4 Million221
    Avita Medical Completes Private Placement Of US$9.5 Million232
    Avita Medical Announces Share Purchase Plan Of US$2.1 Million251
    Avita Medical Completes Private Placement Of US$0.72 Million261
  Asset Transactions271
    Medical Developments Acquires Respiratory Business of Avita Medical for USD1.8 Million272
Avita Medical Ltd - Key Competitors291
Key Employees301
Locations And Subsidiaries311
  Head Office311
  Other Locations &Subsidiaries311
Recent Developments321
Financial Announcements321
Jul 29, 2016: Avita Medical Announces Financial Results for Fourth Quarter Fiscal 2016322
Apr 29, 2016: Avita Medical Announces Financial Results for Third Quarter Fiscal 2016341
Feb 26, 2016: Avita Medical Announces Financial Results for First Half Fiscal 2016353
Jan 28, 2016: Avita Medical Announces Financial Results for Second Quarter Fiscal 2016381
Oct 28, 2015: Avita Medical Announces Financial Results and Provides Corporate Update for First Quarter 2016392
Jul 29, 2015: Avita Medical Announces Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year 2015412
Corporate Communications431
Jun 20, 2016: Avita Medical Appoints a COO and a VP of Sales and Marketing431
Jan 13, 2016: Avita Medical Transforms Board With Three New Appointments442
Apr 14, 2015: Avita Medical Appoints Adam Kelliher as Chief Executive Officer461
Product News471
Mar 15, 2016: Avita Medical Completes Repigmentation Study Enrollment471
Mar 08, 2016: Avita Medical Announces Positive Results from Randomized, Multicentre EU Study of ReGenerCell for Treatment of Chronic Venous Leg Ulcers482
Mar 02, 2016: Avita Medical Launches Regenerative Product ReGenerCell in Europe501
Mar 02, 2016: Avita Medical Launches Regenerative Product ReNovaCell in Europe511
Feb 11, 2016: Avita Medical Appoints Distributor for Germany, Switzerland, Austria521
Dec 14, 2015: FDA Grants ReCell Expedited Access Pathway Designation531
Oct 22, 2015: Avita Medical Announces First Patient Treated in US Military Wound Trial541
Oct 13, 2015: Avita Medical Provides Update on ReCell Success in Treating Burn Victims in Taiwan551
Oct 04, 2015: Avita Medical Announces U.S. FDA Doubles Patient Numbers Permitted for Compassionate Use of ReCell561
Jul 06, 2015: Avita Medical Data Demonstrating ReCell Effectiveness in Skin Repigmentation Published in Journal of the American Academy of Dermatology571
Apr 27, 2015: Avita Medical Granted CE Mark for Expanded ReCell581
Jan 28, 2015: Avita Medical Announces First Patient Enrollment in US Pivotal Study of ReCell for the Treatment of Burns591
Product Approvals601
Dec 14, 2015: FDA Grants ReCell Expedited Access Pathway Designation601
Oct 04, 2015: Avita Medical Announces U.S. FDA Doubles Patient Numbers Permitted for Compassionate Use of ReCell611
Apr 27, 2015: Avita Medical Granted CE Mark for Expanded ReCell621
Clinical Trials631
Mar 15, 2016: Avita Medical Completes Repigmentation Study Enrollment631
Mar 08, 2016: Avita Medical Announces Positive Results from Randomized, Multicentre EU Study of ReGenerCell for Treatment of Chronic Venous Leg Ulcers642
Jan 28, 2015: Avita Medical Announces First Patient Enrollment in US Pivotal Study of ReCell for the Treatment of Burns661
Other Significant Developments671
Sep 28, 2016: Avita Medical Signs Exclusive Distributor Deal in Iran671
Jun 07, 2016: Avita Medical Signs Deal for Distribution in Malaysia681
Feb 05, 2016: Avita Medical Completes Sale of Respiratory Business for $2.47m691
Jan 14, 2016: Avita Medical Appoints Distributors in Japan and South Korea701
Nov 04, 2015: Avita Medical Expands Commercial Reach for ReCell in Wound Care Market with the Appointment of Distributors in France and the UK711
Sep 29, 2015: Avita Medical Awarded US Government Contract Valued at up to $53.9m USD721
Appendix731
  Methodology731
  About GlobalData731
  Contact Us731
  Disclaimer731

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Avita Medical Ltd (AVH) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. May 04, 2025. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Avita-Medical-Ltd-AVH-Medical-Equipment-Deals-and-Alliances-Profile-2148-5593>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Avita Medical Ltd (AVH) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Avita-Medical-Ltd-AVH-Medical-Equipment-Deals-and-Alliances-Profile-2148-5593>
  
US$ 250.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research